You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: RE43596


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE43596
Title:.alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
Abstract: .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Inventor(s): Vazquez; Michael L. (Gurnee, IL), Mueller; Richard A. (Glencoe, IL), Talley; John J. (St. Louis, MO), Getman; Daniel P. (Chesterfield, MO), DeCrescenzo; Gary A. (St. Peters, MO), Freskos; John N. (Clayton, MO), Heintz; Robert M. (Ballwin, MO), Bertenshaw; Deborah E. (Brentwood, MO)
Assignee: G.D. Searle LLC (Chicago, IL)
Application Number:11/788,948
Patent Claim Types:
see list of patent claims
Compound; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent RE43596: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope, claims, and the broader patent landscape is crucial for inventors, researchers, and business professionals. This article will delve into the specifics of United States Patent RE43596, exploring its claims, the legal and technical context, and the tools and methods used in patent landscape analysis.

Understanding Patent Scope and Claims

What are Patent Claims?

Patent claims define the scope of protection granted by a patent. They are the legal boundaries that distinguish the invention from prior art and other existing technologies. The scope of a patent is often measured using metrics such as independent claim length and independent claim count, which can indicate the breadth and clarity of the patent[5].

Importance of Patent Scope

The scope of a patent is critical in determining its validity and enforceability. Broader patents may face challenges due to decreased clarity and questionable validity, while narrower patents may have a higher probability of grant and a shorter examination process[5].

United States Patent RE43596: An Overview

Patent Details

To analyze the scope and claims of United States Patent RE43596, one must first identify the key details of the patent:

  • Application Number: This is essential for tracing the patent's history and related applications.
  • Filing Date: The filing date helps in determining the priority of the patent.
  • Legal Status: Checking if the patent is alive, pending, lapsed, revoked, or expired is vital for understanding its current standing[3].

Claims Analysis

The claims section of the patent is where the inventor outlines what is being patented. For RE43596, each claim must be carefully examined to understand what is protected. Here are some key points to consider:

  • Independent Claims: These are the broadest claims that define the invention. Analyzing their length and count can provide insights into the patent's scope[5].
  • Dependent Claims: These claims are narrower and depend on the independent claims. They often add specific details to the broader claims.

Patent Landscape Analysis

What is Patent Landscape Analysis?

Patent landscape analysis involves mapping the entire landscape of a technology domain to understand the competitive environment, identify trends, and uncover opportunities. This analysis includes:

  • Application Number, Filing Date, and Country: These details help in tracking the global footprint of the patent[3].
  • Legal Status and Expected Expiry Dates: Knowing the status and expiry dates of related patents aids in strategic decision-making[3].

Tools for Patent Landscape Analysis

Several tools and resources are available for conducting a thorough patent landscape analysis:

  • Patent Public Search: The USPTO's Patent Public Search tool provides enhanced access to prior art and modern interfaces for searching patents[1].
  • Global Dossier: This service allows users to view the patent family for a specific application, including related applications from participating IP Offices[1].
  • PatentsView: This platform, developed by the USPTO, offers visualization, data dissemination, and analysis of intellectual property data[4].

Technical Context of RE43596

Prior Art and Anticipation

Understanding the prior art is crucial in determining the novelty and non-obviousness of the invention. For RE43596, any prior art patents or publications that could potentially anticipate the claims must be identified. The Patent Trial and Appeal Board's decisions, such as in the case of Arbutus Biopharma Corporation v. Moderna, highlight the importance of prior art in invalidating claims[2].

Classification and Citation Data

Using patent classification systems, such as those provided by the USPTO or international offices like the EPO, can help in organizing and searching for related patents. The Common Citation Document (CCD) application consolidates citation data from participating IP Offices, making it easier to visualize the prior art landscape[1].

Legal Context and Validity

Office Actions and Examination Data

The Patent Examination Data System (PEDS) and Office Action Indicators within the Global Dossier can provide insights into the examination process and any office actions related to the patent. This information is vital for understanding the legal challenges the patent may have faced[1].

Litigation and Appeals

Any litigation or appeals related to RE43596, such as those involving the Patent Trial and Appeal Board, can offer valuable insights into the patent's validity and the legal arguments surrounding it[2].

Conducting a Preliminary Patent Search

To analyze RE43596 effectively, one must conduct a thorough preliminary patent search:

  • Step-by-Step Strategy: The USPTO provides a step-by-step strategy for conducting a preliminary U.S. patent search, which includes using the Patent Public Search tool and other resources[1].
  • International Search: Searching international patent databases, such as those provided by the EPO, JPO, and WIPO, is essential to ensure the invention is novel globally[1].

Key Takeaways

  • Patent Claims: The scope of a patent is defined by its claims, which must be carefully analyzed to understand the protection granted.
  • Patent Landscape Analysis: This analysis helps in understanding the competitive environment and identifying trends and opportunities.
  • Technical and Legal Context: Prior art, classification, and legal challenges are crucial in determining the validity and enforceability of a patent.
  • Tools and Resources: Utilizing tools like Patent Public Search, Global Dossier, and PatentsView can enhance the analysis process.

FAQs

What is the importance of independent claims in a patent?

Independent claims are the broadest claims in a patent and define the invention. They are critical in determining the scope of the patent and are often used as a metric to measure patent breadth and clarity[5].

How can I conduct a preliminary patent search for RE43596?

You can conduct a preliminary patent search using the USPTO's Patent Public Search tool, following a step-by-step strategy provided by the USPTO. Additionally, searching international patent databases is essential to ensure global novelty[1].

What is patent landscape analysis, and how does it help?

Patent landscape analysis involves mapping the technology domain to understand the competitive environment, identify trends, and uncover opportunities. It helps in strategic decision-making by providing insights into the legal status, expected expiry dates, and global footprint of related patents[3].

How do I check the legal status of a patent?

You can check the legal status of a patent using tools like the Global Dossier, which provides access to the file histories and legal status of related applications from participating IP Offices[1].

What is the role of prior art in patent validity?

Prior art is crucial in determining the novelty and non-obviousness of an invention. If prior art anticipates the claims of a patent, it can lead to the invalidation of those claims, as seen in cases like Arbutus Biopharma Corporation v. Moderna[2].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. CAFC - ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC.: https://cafc.uscourts.gov/opinions-orders/20-1183.OPINION.4-11-2023_2108936.pdf
  3. Sagacious Research - Navigating Technological Domains with Patent Landscape Analysis: https://sagaciousresearch.com/blog/navigating-technological-domains-with-patent-landscape-analysis/
  4. Brown University Library Guides - Patents: https://libguides.brown.edu/patent
  5. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE43596

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent RE43596

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0810209 ⤷  Subscribe 07C0034 France ⤷  Subscribe
European Patent Office 0810209 ⤷  Subscribe CA 2007 00017 Denmark ⤷  Subscribe
European Patent Office 0810209 ⤷  Subscribe SPC/GB07/038 United Kingdom ⤷  Subscribe
European Patent Office 0810209 ⤷  Subscribe 2007/024 Ireland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.